Friday, September 06, 2019 1:30:29 PM
http://tinyurl.com/GBM-survivor-Nate-Bilinski
With approval from his oncologist, Nate underwent grueling tests to see if he was a suitable candidate for it. He was accepted in DC Vax, an immunotherapy treatment program which used Nate’s own cells to fight the cancer within him.
For two years, the collaboration was constant between Nate’s local oncology team and his clinical trial team at the U-M. After every treatment and every surgery, there were reports and emails exchanged to bring each other up to speed on Nate’s progress. The immunotherapy and six surgeries were done at the U-M, while his chemo and radiation were here.
The process worked well, so well that when Nate made it to the end of the clinical trial, no one quite knew what to do next. People rarely survived this and yet his tumor was gone. The clinical trial worked exactly the way the doctors intended.
Now, 5 years later, Nate is cancer free. His doctors aren’t as worried anymore about recurrence. He only takes medication for seizures, a side effect, though they’re rare.
As that report was in 2017 so it looks like he lived another 7 years after treatment.
As they say in the X-Files, the truth is out there. Just google 'smith on stocks on Illegal Naked Shorting'
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
